NIH Reporter #11371231

NCI Research Grant: TRPV1 Role in Triple-Negative Breast Cancer Innervation

This opportunity is a research grant from the National Cancer Institute (NCI), part of the NIH, focused on understanding the role of TRPV1 in the innervation of triple-negative breast cancer (TNBC). - Government Buyer: - National Cancer Institute (NCI), National Institutes of Health (NIH) - Project Scope: - Research on TRPV1's involvement in sensory nerve recruitment in TNBC - Studies to include in vitro, 3D hydrogel, and in vivo mouse model experiments - Project based at Tufts University, Boston, MA - Products/Services Requested: - Scientific research services (no commercial products specified) - Unique Requirements: - Expertise in cancer biology and neurobiology - Advanced laboratory techniques for cellular and animal models - OEMs and Vendors: - No specific OEMs or commercial vendors mentioned, as this is a research grant - Estimated Award Amount: - $55,114 - Notable Details: - Focus on basic and translational cancer research - Emphasis on mechanistic studies of nerve-cancer interactions

Description

This is a research grant opportunity from the NIH for studying the mechanisms of sensory nerve recruitment in triple-negative breast cancer, focusing on the role of TRPV1. The project involves in vitro, 3D hydrogel, and in vivo mouse model studies. The research aims to understand the biological processes related to cancer innervation. The award amount is approximately $55,114, with a project duration from July 1, 2024, to June 30, 2028.

View original listing